Trevi Therapeutics, Inc. TRVI Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1?
- Trevi Therapeutics, Inc. (TRVI) reported sharebased compensation arrangement by sharebased payment award options vested in period fair value1 of $1.13M in Q4 2025.
- How has Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1 changed year-over-year?
- Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1 increased by 87.5% year-over-year, from $600K to $1.13M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s sharebased compensation arrangement by sharebased payment award options vested in period fair value1 has grown at a 17.0% compound annual growth rate (CAGR), from $2.4M to $4.5M.
- What does sharebased compensation arrangement by sharebased payment award options vested in period fair value1 mean?
- The total fair value of stock options that completed their vesting period during the reporting year. This represents the portion of equity compensation expense recognized as employees fulfill their service requirements.